Variant report

Variant	esv3398888
Chromosome Location	chr6:131455859-131457857
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr6:131457111-131457634	HepG2	liver:	n/a	n/a
2	ARID3A	chr6:131456357-131456657	HepG2	liver:	n/a	n/a
3	BACH1	chr6:131456427-131456648	H1-hESC	embryonic stem cell:	n/a	n/a
4	BHLHE40	chr6:131457013-131457179	GM12878	blood:	n/a	n/a
5	BHLHE40	chr6:131456349-131457263	HepG2	liver:	n/a	chr6:131456953-131456969 chr6:131456961-131456977
6	BHLHE40	chr6:131457109-131457125	K562	blood:	n/a	n/a
7	BRCA1	chr6:131456609-131456644	H1-hESC	embryonic stem cell:	n/a	n/a
8	BRCA1	chr6:131456401-131456653	HepG2	liver:	n/a	n/a
9	BRCA1	chr6:131455939-131456362	Hela-S3	cervix:	n/a	n/a
10	CBX3	chr6:131456323-131456630	K562	blood:	n/a	n/a
11	CCNT2	chr6:131456367-131457090	K562	blood:	n/a	n/a
12	CEBPB	chr6:131456223-131456482	HepG2	liver:	n/a	chr6:131456292-131456305 chr6:131456294-131456305 chr6:131456292-131456303 chr6:131456294-131456305
13	CEBPB	chr6:131456121-131456535	HepG2	liver:	n/a	chr6:131456292-131456305 chr6:131456294-131456305 chr6:131456292-131456303 chr6:131456294-131456305
14	CEBPB	chr6:131456011-131456610	A549	lung:	n/a	chr6:131456292-131456305 chr6:131456294-131456305 chr6:131456292-131456303 chr6:131456294-131456305
15	CEBPB	chr6:131456151-131456467	K562	blood:	n/a	chr6:131456292-131456305 chr6:131456294-131456305 chr6:131456292-131456303 chr6:131456294-131456305
16	CEBPB	chr6:131456119-131456483	A549	lung:	n/a	chr6:131456292-131456305 chr6:131456294-131456305 chr6:131456292-131456303 chr6:131456294-131456305
17	CEBPB	chr6:131456112-131456482	IMR90	lung:	n/a	chr6:131456292-131456305 chr6:131456294-131456305 chr6:131456292-131456303 chr6:131456294-131456305
18	CEBPB	chr6:131456111-131456472	ECC-1	luminal epithelium:	n/a	chr6:131456292-131456305 chr6:131456294-131456305 chr6:131456292-131456303 chr6:131456294-131456305
19	CEBPB	chr6:131456079-131456574	Hela-S3	cervix:	n/a	chr6:131456292-131456305 chr6:131456294-131456305 chr6:131456292-131456303 chr6:131456294-131456305
20	CEBPB	chr6:131456103-131456505	MCF-7	breast:	n/a	chr6:131456292-131456305 chr6:131456294-131456305 chr6:131456292-131456303 chr6:131456294-131456305
21	CEBPB	chr6:131456218-131456450	H1-hESC	embryonic stem cell:	n/a	chr6:131456292-131456305 chr6:131456294-131456305 chr6:131456292-131456303 chr6:131456294-131456305
22	CEBPB	chr6:131456107-131456516	A549	lung:	n/a	chr6:131456292-131456305 chr6:131456294-131456305 chr6:131456292-131456303 chr6:131456294-131456305
23	CEBPD	chr6:131456340-131457209	HepG2	liver:	n/a	n/a
24	CEBPD	chr6:131456548-131456921	HepG2	liver:	n/a	n/a
25	CHD2	chr6:131456345-131456762	H1-hESC	embryonic stem cell:	n/a	n/a
26	CHD2	chr6:131456253-131456730	HepG2	liver:	n/a	n/a
27	CHD2	chr6:131456536-131456547	GM12878	blood:	n/a	n/a
28	CHD2	chr6:131456526-131456726	K562	blood:	n/a	n/a
29	CHD2	chr6:131457045-131457245	H1-hESC	embryonic stem cell:	n/a	n/a
30	CHD2	chr6:131456225-131457275	Hela-S3	cervix:	n/a	n/a
31	CHD2	chr6:131456936-131457662	HepG2	liver:	n/a	n/a
32	CREB1	chr6:131456214-131457650	HepG2	liver:	n/a	n/a
33	CREB1	chr6:131456202-131456768	H1-hESC	embryonic stem cell:	n/a	n/a
34	CREB1	chr6:131456298-131456973	H1-hESC	embryonic stem cell:	n/a	n/a
35	CREB1	chr6:131456294-131456996	A549	lung:	n/a	n/a
36	CTCF	chr6:131456925-131456932	GM10248	blood:	n/a	n/a
37	CTCF	chr6:131457040-131457190	HEK293	kidney:	n/a	n/a
38	CTCF	chr6:131456930-131456931	GM12878	blood:	n/a	n/a
39	CTCF	chr6:131456873-131456949	LNCaP	prostate:	n/a	n/a
40	CTCF	chr6:131457040-131457190	SAEC	small airway:	n/a	n/a
41	CTCF	chr6:131456837-131456986	GM19238	blood:	n/a	n/a
42	CTCF	chr6:131457260-131457410	AG10803	skin:	n/a	n/a
43	CTCF	chr6:131456896-131456920	GM10248	blood:	n/a	n/a
44	CTCF	chr6:131456855-131456861	GM10248	blood:	n/a	n/a
45	CTCF	chr6:131457020-131457170	HRE	kidney:	n/a	n/a
46	CTCF	chr6:131456779-131457038	Fibrobl	skin:	n/a	n/a
47	CTCF	chr6:131456860-131457010	AG09319	gingival:	n/a	n/a
48	CTCF	chr6:131456866-131456984	MCF-7	breast:	n/a	n/a
49	CTCF	chr6:131457600-131457750	HMF	breast:	n/a	n/a
50	CTCF	chr6:131456848-131456944	Spleen_OC	spleen:	n/a	n/a

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr6:131457506-131457556	SK-N-MC	brain:	n/a
2	chr6:131456365-131456415	HRE	kidney:	n/a
3	chr6:131456780-131456830	HMEC	breast:	n/a
4	chr6:131457506-131457556	GM12891	blood:	n/a
5	chr6:131456780-131456830	AG09309	skin:	n/a
6	chr6:131457146-131457196	Caco-2	colon:	n/a
7	chr6:131456365-131456415	PFSK-1	brain:	n/a
8	chr6:131457506-131457556	AG10803	skin:	n/a
9	chr6:131456785-131456835	PrEC	prostate:	n/a
10	chr6:131456365-131456415	T-47D	breast:	n/a
11	chr6:131457146-131457196	PrEC	prostate:	n/a
12	chr6:131456780-131456830	HRE	kidney:	n/a
13	chr6:131456780-131456830	PrEC	prostate:	n/a
14	chr6:131457146-131457196	AoSMC	blood vessel:	n/a
15	chr6:131456785-131456835	NHBE	bronchial:	n/a
16	chr6:131457506-131457556	NT2-D1	testis:	n/a
17	chr6:131456780-131456830	CMK	blood:	n/a
18	chr6:131456780-131456830	GM12878	blood:	n/a
19	chr6:131457506-131457556	IMR90	lung:	fetal
20	chr6:131457506-131457556	HCM	heart:	n/a
21	chr6:131456365-131456415	NH-A	brain:	n/a
22	chr6:131456365-131456415	ProgFib	skin:	n/a
23	chr6:131456785-131456835	IMR90	lung:	fetal
24	chr6:131457506-131457556	HUVEC	blood vessel:	n/a
25	chr6:131457506-131457556	HepG2	liver:	n/a
26	chr6:131457506-131457556	Jurkat	blood:	n/a
27	chr6:131456365-131456415	AG04449	skin:	fetal
28	chr6:131457146-131457196	HCT-116	colon:	n/a
29	chr6:131456780-131456830	HUVEC	blood vessel:	n/a
30	chr6:131456785-131456835	SAEC	small airway:	n/a
31	chr6:131456365-131456415	HUVEC	blood vessel:	n/a
32	chr6:131457146-131457196	HAEpiC	amniotic membrane:	n/a
33	chr6:131456785-131456835	LNCaP	prostate:	n/a
34	chr6:131457146-131457196	HPAEpiC	pulmonary alveolar:	n/a
35	chr6:131456780-131456830	NB4	blood:	n/a
36	chr6:131456780-131456830	T-47D	breast:	n/a
37	chr6:131457506-131457556	HPAEpiC	pulmonary alveolar:	n/a
38	chr6:131457506-131457556	HAEpiC	amniotic membrane:	n/a
39	chr6:131456365-131456415	Hepatocyte	liver:	n/a
40	chr6:131456780-131456830	Hepatocyte	liver:	n/a
41	chr6:131456365-131456415	IMR90	lung:	fetal
42	chr6:131457146-131457196	SKMC	muscle:	n/a
43	chr6:131456365-131456415	HCM	heart:	n/a
44	chr6:131456780-131456830	Hela-S3	cervix:	n/a
45	chr6:131456785-131456835	HepG2	liver:	n/a
46	chr6:131457146-131457196	SK-N-MC	brain:	n/a
47	chr6:131457146-131457196	BE2_C	brain:	n/a
48	chr6:131456780-131456830	NHBE	bronchial:	n/a
49	chr6:131456780-131456830	HCM	heart:	n/a
50	chr6:131457146-131457196	SK-N-SH	brain:	n/a

No.	Distal block	Cell Line	Cell type
1	chr1:1509737..1510642-chr6:131456190..131456991,2	Hela-S3	cervix:
2	chr15:69744952..69745682-chr6:131456347..131457188,2	Hela-S3	cervix:
3	chr11:62609119..62609619-chr6:131456326..131457092,2	HCT-116	colon:
4	chr6:131452705..131454330-chr6:131455080..131456599,2	K562	blood:
5	chr6:131456917..131458462-chr6:131459846..131461723,2	MCF-7	breast:
6	chr6:131455039..131456597-chr6:131460458..131462514,2	K562	blood:

Variant related genes	Relation type
AKAP7	TF binding region
AKAP7	CpG island
ENSG00000133316	chromatin interactions
ENSG00000137818	chromatin interactions
ENSG00000215014	chromatin interactions
ENSG00000160075	chromatin interactions

Extended variants
information (count: 76 )
Associated
traits (count: 78 )

Variant overlapped rSNPs/rCNVs (count:76 , 50 per page) page: 1 2

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs536462443	chr6:131455859-131455860	Enhancers Weak transcription Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
2	rs186904818	chr6:131455870-131455871	Enhancers Weak transcription Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
3	rs373097922	chr6:131455874-131455875	Enhancers Weak transcription Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
4	rs567175708	chr6:131455891-131455892	Enhancers Weak transcription Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
5	rs534486421	chr6:131455902-131455903	Enhancers Weak transcription Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
6	rs559038743	chr6:131455947-131455948	Enhancers Weak transcription Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
7	rs191415525	chr6:131455980-131455981	Enhancers Weak transcription Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
8	rs117364854	chr6:131456023-131456024	Active TSS Weak transcription Enhancers Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
9	rs145384565	chr6:131456037-131456038	Active TSS Weak transcription Enhancers Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
10	rs149219051	chr6:131456048-131456049	Active TSS Weak transcription Enhancers Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
11	rs531038002	chr6:131456128-131456129	Active TSS Weak transcription Enhancers Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
12	rs552083573	chr6:131456201-131456202	Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
13	rs144196718	chr6:131456227-131456228	Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
14	rs572051501	chr6:131456246-131456247	Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
15	rs545692637	chr6:131456260-131456261	Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
16	rs183634170	chr6:131456289-131456290	Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
17	rs376289008	chr6:131456314-131456315	Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
18	rs187184787	chr6:131456353-131456354	Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
19	rs192604286	chr6:131456396-131456397	Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS	TF binding region CpG island Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
20	rs528936654	chr6:131456402-131456403	Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers	TF binding region CpG island Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
21	rs115049551	chr6:131456439-131456440	Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
22	rs114078321	chr6:131456448-131456449	Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
23	rs528020246	chr6:131456503-131456504	Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
24	rs552888931	chr6:131456522-131456523	Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
25	rs571122535	chr6:131456645-131456646	Active TSS Bivalent/Poised TSS Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
26	rs76653576	chr6:131456653-131456654	Active TSS Bivalent/Poised TSS Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
27	rs556472469	chr6:131456657-131456658	Active TSS Bivalent/Poised TSS Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
28	rs9483222	chr6:131456691-131456692	Active TSS Bivalent/Poised TSS Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
29	rs9402320	chr6:131456733-131456734	Active TSS Bivalent/Poised TSS Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	5 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
30	rs535937641	chr6:131456773-131456774	Active TSS Bivalent/Poised TSS Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
31	rs553599339	chr6:131456776-131456777	Active TSS Bivalent/Poised TSS Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
32	rs571890399	chr6:131456779-131456780	Active TSS Bivalent/Poised TSS Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
33	rs545729457	chr6:131456805-131456806	Active TSS Bivalent/Poised TSS Enhancers Bivalent Enhancer	TF binding region CpG island Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
34	rs112523434	chr6:131456862-131456863	Active TSS Bivalent/Poised TSS Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
35	rs111320335	chr6:131456867-131456868	Active TSS Bivalent/Poised TSS Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
36	rs568377766	chr6:131456930-131456931	Active TSS Bivalent/Poised TSS Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
37	rs575904406	chr6:131456946-131456947	Active TSS Bivalent/Poised TSS Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
38	rs543055475	chr6:131456948-131456949	Active TSS Bivalent/Poised TSS Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
39	rs539087422	chr6:131456953-131456954	Active TSS Bivalent/Poised TSS Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
40	rs62422438	chr6:131456968-131456969	Active TSS Bivalent/Poised TSS Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
41	rs9402321	chr6:131456982-131456983	Active TSS Bivalent/Poised TSS Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	5 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
42	rs529025310	chr6:131456995-131456996	Active TSS Bivalent/Poised TSS Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
43	rs189917365	chr6:131457036-131457037	Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent/Poised TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
44	rs560702643	chr6:131457038-131457039	Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent/Poised TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
45	rs527900399	chr6:131457097-131457098	Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent/Poised TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
46	rs552774506	chr6:131457102-131457103	Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent/Poised TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
47	rs571162154	chr6:131457176-131457177	Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
48	rs9388886	chr6:131457195-131457196	Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent/Poised TSS	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
49	rs1746479	chr6:131457295-131457296	Active TSS Flanking Bivalent TSS/Enh Weak transcription Bivalent/Poised TSS Flanking Active TSS	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
50	rs77095004	chr6:131457297-131457298	Active TSS Flanking Bivalent TSS/Enh Weak transcription Bivalent/Poised TSS Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:78)

Disease	PMID	Source
Uveal melanoma	21693616	CNVD
Glioblastoma multiforme	21080181	CNVD
Biliary cancer	19435499	CNVD
Medulloblastoma	21979893	CNVD
Malaria	21533027	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Ewing''s sarcoma	17952124	CNVD
Autism	21448237	CNVD
Autism	22495311	CNVD
Biliary cancer	20360734	CNVD
Breast cancer	20360734	CNVD
Coronary artery disease	20360734	CNVD
Crohn''s disease	20360734	CNVD
Hypertension	20360734	CNVD
Rheumatoid arthritis	20360734	CNVD
Type 1 diabetes	20360734	CNVD
Type 2 diabetes	20360734	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Neuroblastoma	18923191	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Melanoma	18172304	CNVD
Cancer	21637783	CNVD
Colorectal cancer	16272173	CNVD
Gastric cancer	17908304	CNVD
lymphocytic leukemia	21291569	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Follicular lymphoma	19010834	CNVD
Non-small cell lung cancer	21044232	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Phyllodes tumor	17334353	CNVD
Breast cancer	16608533	CNVD
Non-small cell lung cancer	21385341	CNVD
Prostate cancer	16705090	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Ependymoma	16718352	CNVD
High-proliferative meningiomas	17937814	CNVD
Intracranial tumor	16823260	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Breast cancer	16272173	CNVD
Prostate cancer	18632612	CNVD
Wilms tumour	21544195	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Glioma	21046410	CNVD
Primary central nervous system lymphoma	21088137	CNVD
Zellweger syndrome	21572526	CNVD
Follicular lymphoma	20505157	CNVD
Congenital diaphragmatic hernia	21085971	CNVD
Malignant melanoma	18718029	CNVD
Lung adenocarcinoma	21935476	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Lung cancer	18438408	CNVD
Breast cancer	21858162	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Breast cancer	17603634	CNVD
Chondromyxoid Fibroma	20696777	CNVD
Cancer	21183584	CNVD
Developmental delay	19490664	CNVD
Non-muscle invasive bladder neoplasm	19445696	CNVD
Burkitt''s lymphoma	18698080	CNVD
Breast cancer	21785460	CNVD
Kartagener syndrome	16639409	CNVD
Breast cancer	17133270	CNVD
Follicular lymphoma	18703704	CNVD
Neurodevelopmental disorder	22521361	CNVD
small cell lung cancer	20016488	CNVD
Adenoid cystic carcinoma	18698036	CNVD
head and neck squamous cell carcinoma	17671120	CNVD
Leukemia	18688285	CNVD
Breast cancer	21364760	CNVD
Myelofibrosis	22110671	CNVD
Renal cell carcinoma	18592004	CNVD

Chromatin state (count:398 , 50 per page) page: 1 2 3 4 5 6 7 8

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr6:131446000-131456200	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
2	chr6:131449000-131456000	Weak transcription	Fetal Brain Male	brain
3	chr6:131455000-131456200	Enhancers	Small Intestine	intestine
4	chr6:131455400-131456200	Weak transcription	Fetal Muscle Trunk	muscle
5	chr6:131455400-131456200	Enhancers	Sigmoid Colon	Sigmoid Colon
6	chr6:131455600-131456000	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
7	chr6:131455600-131456000	Flanking Active TSS	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
8	chr6:131455600-131456000	Enhancers	Primary T helper cells PMA-I stimulated	--
9	chr6:131455600-131456000	Enhancers	Cortex derived primary cultured neurospheres	brain
10	chr6:131455600-131456000	Enhancers	Foreskin Melanocyte Primary Cells skin01	Skin
11	chr6:131455600-131456000	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
12	chr6:131455600-131456000	Flanking Active TSS	Brain Dorsolateral Prefrontal Cortex	brain
13	chr6:131455600-131456000	Flanking Active TSS	Brain Substantia Nigra	brain
14	chr6:131455600-131456000	Enhancers	Colon Smooth Muscle	Colon
15	chr6:131455600-131456000	Enhancers	Fetal Adrenal Gland	Adrenal Gland
16	chr6:131455600-131456000	Flanking Active TSS	Fetal Lung	lung
17	chr6:131455600-131456000	Flanking Active TSS	HepG2	liver
18	chr6:131455600-131456200	Enhancers	Primary T helper memory cells from peripheral blood 1	blood
19	chr6:131455600-131456400	Flanking Active TSS	Primary hematopoietic stem cells	blood
20	chr6:131455600-131456400	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--
21	chr6:131455600-131458000	Active TSS	Pancreatic Islets	Pancreatic Islet
22	chr6:131455600-131458200	Active TSS	Stomach Smooth Muscle	stomach
23	chr6:131455800-131456000	Enhancers	ES-I3 Cell Line	embryonic stem cell
24	chr6:131455800-131456000	Enhancers	H1 Cell Line	embryonic stem cell
25	chr6:131455800-131456000	Flanking Bivalent TSS/Enh	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
26	chr6:131455800-131456000	Bivalent Enhancer	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
27	chr6:131455800-131456000	Bivalent Enhancer	HUES48 Cell Line	embryonic stem cell
28	chr6:131455800-131456000	Active TSS	HUES6 Cell Line	embryonic stem cell
29	chr6:131455800-131456000	Bivalent Enhancer	iPS-15b Cell Line	embryonic stem cell
30	chr6:131455800-131456000	Flanking Active TSS	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
31	chr6:131455800-131456000	Flanking Active TSS	Breast Myoepithelial Primary Cells	Breast
32	chr6:131455800-131456000	Flanking Active TSS	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
33	chr6:131455800-131456000	Enhancers	Primary monocytes fromperipheralblood	blood
34	chr6:131455800-131456000	Enhancers	Primary T helper naive cells fromperipheralblood	blood
35	chr6:131455800-131456000	Bivalent Enhancer	Primary T helper 17 cells PMA-I stimulated	--
36	chr6:131455800-131456000	Flanking Active TSS	Foreskin Fibroblast Primary Cells skin02	Skin
37	chr6:131455800-131456000	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
38	chr6:131455800-131456000	Flanking Active TSS	Brain Anterior Caudate	brain
39	chr6:131455800-131456000	Flanking Active TSS	Brain Cingulate Gyrus	brain
40	chr6:131455800-131456000	Flanking Active TSS	Brain Hippocampus Middle	brain
41	chr6:131455800-131456000	Enhancers	Duodenum Mucosa	Duodenum
42	chr6:131455800-131456000	Enhancers	Fetal Heart	heart
43	chr6:131455800-131456000	Enhancers	Fetal Intestine Large	intestine
44	chr6:131455800-131456000	Flanking Active TSS	Fetal Intestine Small	intestine
45	chr6:131455800-131456000	Active TSS	Fetal Kidney	kidney
46	chr6:131455800-131456000	Flanking Active TSS	Fetal Muscle Leg	muscle
47	chr6:131455800-131456000	Enhancers	Fetal Stomach	stomach
48	chr6:131455800-131456000	Flanking Active TSS	Ovary	ovary
49	chr6:131455800-131456000	Enhancers	Right Atrium	heart
50	chr6:131455800-131456000	Enhancers	Skeletal Muscle Male	skeletal muscle

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links